Tzvi Palash
2010
In 2010, Tzvi Palash earned a total compensation of $303.1K as Chief Operating Officer at Protalix BioTherapeutics.
Compensation breakdown
Option Awards | $207,075 |
---|---|
Salary | $71,956 |
Other | $24,094 |
Total | $303,125 |
Palash received $207.1K in option awards, accounting for 68% of the total pay in 2010.
Palash also received $72K in salary and $24.1K in other compensation.
Rankings
In 2010, Tzvi Palash's compensation ranked 9,047th out of 10,439 executives tracked by ExecPay. In other words, Palash earned more than 13.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,047 out of 10,439 | 13th |
Division Manufacturing | 3,368 out of 3,838 | 12th |
Major group Chemicals And Allied Products | 812 out of 921 | 12th |
Industry group Drugs | 589 out of 680 | 13th |
Industry Biological Products, Except Diagnostic Substances | 120 out of 142 | 16th |
Source: SEC filing on September 19, 2013.
Palash's colleagues
We found five more compensation records of executives who worked with Tzvi Palash at Protalix BioTherapeutics in 2010.
2010
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2010
Sandra Lauterbach
Protalix BioTherapeutics
Vice President, Sales and Commercial Affairs
2010
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2010
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2010
Yossi Maimon
Protalix BioTherapeutics